XML 54 R44.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-Based Compensation (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]    
Summary of Stock-based Compensation Expense
The Company recorded stock-based compensation expense for stock options and RSUs as follows:
 
    
Three Months
Ended
September 30,
    
Nine Months

Ended

September 30,
 
(Amounts in thousands)
  
2025
    
2024
    
2025
    
2024
 
Research and development
   $ 3,700      $ 189      $ 12,871      $ 539  
Selling, general and administrative
     5,786        170        15,221        503  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 9,486      $ 359      $ 28,092      $ 1,042  
  
 
 
    
 
 
    
 
 
    
 
 
 
The Company recorded stock-based compensation expense for stock options and the
2024
cancellation of
135,400
RSUs during the years ended December 
31
,
2024
and
2023
, as follows (in thousands):
 
 
  
2024
 
  
2023
 
Research and development
   $ 1,106      $ 372  
Selling, general and administrative
     2,741        2,111  
Total
   $ 3,847      $ 2,483  
Summary of Stock Option Activity
A summary of stock option activity is as follows:
 
(Value in thousands, life in years)
  
Number of
options
    
Weighted
average
exercise
price
    
Weighted
average
remaining
contractual
life
    
Aggregate
intrinsic
value
 
Outstanding as of December 31, 2024
     28,360,635      $ 1.27        9.2      $ 22,741  
Granted
     1,347,536        3.57        
Exercised
     (15,080      1.18        
Forfeited
     (374,308      1.31        
  
 
 
    
 
 
       
Outstanding as of September 30, 2025
     29,318,783      $ 1.37        8.5        68,324  
  
 
 
    
 
 
       
Vested and expected to vest as of September 30, 2025
     29,318,783      $ 1.37        8.5        68,324  
  
 
 
    
 
 
       
Exercisable as of September 30, 2025
     15,847,903      $ 1.48        8.1        38,507  
  
 
 
    
 
 
       
A summary of stock option activity as of December 31, 2024 is as follows:
 

    
Number of
options
outstanding
    
Weighted
average
exercise
price
    
Weighted
average
remaining
contractual
life
    
Aggregate
intrinsic
value
(in
thousands)
 
Outstanding options at December 31, 2022
     1,325,844      $ 9.10        5.6      $ 925  
Granted
     15,141,280        0.44        
Exercised
     (1,000      0.80        
Expired
     (8,601      0.80        
Forfeited
     (19,543      15.53        
  
 
 
    
 
 
       
Outstanding options at December 31, 2023
     16,437,980      $ 1.12        9.3      $ 13,907  
Granted
     21,329,457        0.92        
Exercised
     (65,646      1.49        
Expired
     (5,500      0.74        
Forfeited
     (1,333,107      1.54        
  
 
 
    
 
 
       
Outstanding options at December 31, 2024
     36,363,184      $ 0.99        9.2      $ 22,845  
  
 
 
    
 
 
       
Vested/expected to vest at December 31, 2024
     35,560,434      $ 0.99        9.1      $ 22,492  
Exercisable options at December 31, 2024
     9,614,865      $ 1.58        8.3      $ 7,066  
Summary of RSU Activity Issued
A summary of the Company’s RSU activity is as follows:
 
    
Number of
RSUs
(1)
    
Weighted
average
grant date
fair value
 
Balance as of December 31, 2024
     3,630,447      $ 1.53  
Granted
     8,872,307        2.67  
Issued
     (1,331,257      2.64  
Forfeited
     (406,649      2.29  
  
 
 
    
 
 
 
Balance as of September 30, 2025
     10,764,848      $ 2.30  
  
 
 
    
 
 
 
 
(1)
 
As of September 30, 2025, 1,973,365 of the RSUs have vested but have not yet been issued to the award holders. As no conditions remain in order for these shares of common stock to be issuable, these awards have been included in the weighted average shares outstanding calculation for purposes of earnings per share (see Note 18).
A summary of the Company’s RSU activity issued under the 2011 Amended Plan, inclusive of the
6,000,000 RSUs issued to an investor (see Notes 7 and 13), for the years ended December 31, 2024 and 2023 is as follows:
 
 
  
Awards
 
  
Weighted-
average grant
date fair value
(per share)
 
Nonvested as of January 1, 2023
     137,909      $ 15.28  
Issued
     10,929,820      $ 0.60  
Exercised
     (6,000,000    $ 0.44  
Forfeited
     (150,900    $ 1.98  
  
 
 
    
 
 
 
Nonvested as of December 31, 2023
     4,916,829      $ 1.18  
Forfeited
     (254,555    $ 0.88  
Expired
     (7,000    $ 0.82  
  
 
 
    
 
 
 
Nonvested as of December 31, 2024
     4,655,274      $ 1.19  
  
 
 
    
 
 
 
Summary of Fair Value of Options Issued using Black-Scholes Option Pricing Model The fair value of the options issued was determined using the Black-Scholes option pricing model, using the following inputs:
 
    
Three and
Nine Months
Ended
September 30,
2025
 
Weighted average exercise price (per share)
   $ 3.57  
Risk-free rate
     3.7
Expected life (in years)
     5.6  
Expected volatility rate
     60.7
Dividend yield rate
     —